Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Analysis of Short-term (Operating) Activity Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check

Short-term Activity Ratios (Summary)

Abbott Laboratories, short-term (operating) activity ratios (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Turnover Ratios
Inventory turnover
Receivables turnover
Payables turnover
Working capital turnover
Average No. Days
Average inventory processing period
Add: Average receivable collection period
Operating cycle
Less: Average payables payment period
Cash conversion cycle

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The operating activity ratios indicate a general lengthening of the working capital cycle from 2022 through 2026, characterized by a systemic decline in inventory and receivables efficiency.

Inventory Management
Inventory turnover experienced a downward trend from 3.36 in early 2022 to a low of 2.62 by mid-2023. This is reflected in the average inventory processing period, which extended from 109 days to a peak of 139 days. Although a brief improvement occurred in late 2024, the processing period remained elevated, fluctuating between 123 and 138 days through mid-2026.
Receivables Efficiency
A consistent decline in receivables turnover is observable, falling from 6.20 in March 2022 to 5.42 by June 2026. Correspondingly, the average receivable collection period increased from 59 days to 67 days. This trend suggests a gradual deterioration in the speed of credit recovery over the analyzed period.
Payables and Liquidity
Payables turnover and the average payables payment period remained relatively stable. The payment period fluctuated within a narrow range between 78 and 91 days, indicating a consistent approach to managing supplier obligations without significant shifts in payment terms.
Working Capital Turnover
Working capital turnover remained largely stable, ranging between 3.63 and 4.83 for the majority of the timeframe. However, a sharp increase is observed in the first half of 2026, with the ratio climbing to 6.33 in March and reaching 6.95 by June 2026, suggesting a marked optimization in the utilization of net working capital relative to sales.
Operating and Cash Conversion Cycles
The operating cycle lengthened from 168 days in early 2022 to 199 days by mid-2026. Consequently, the cash conversion cycle increased from 77 days to 112 days. This expansion is primarily attributable to the combined effects of slower inventory movement and longer receivable collection times, which were not offset by changes in the payables payment period.

Turnover Ratios


Average No. Days



Inventory Turnover

Abbott Laboratories, inventory turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets
Inventories
Short-term Activity Ratio
Inventory turnover1
Benchmarks
Inventory Turnover, Competitors2
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Inventory turnover = (Cost of products sold, excluding amortization of intangible assetsQ2 2026 + Cost of products sold, excluding amortization of intangible assetsQ1 2026 + Cost of products sold, excluding amortization of intangible assetsQ4 2025 + Cost of products sold, excluding amortization of intangible assetsQ3 2025) ÷ Inventories
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


An analysis of the operating activity ratios reveals a general contraction in inventory efficiency from early 2022 through mid-2026, characterized by a period of volatility followed by a plateau and a recent decline.

Inventory Turnover Trend
The inventory turnover ratio began at 3.36 in March 2022 and experienced a downward trajectory, reaching a trough of 2.62 by June 2023. While the ratio stabilized between 2.65 and 2.88 for much of 2023 through 2025, it failed to return to the initial 2022 efficiency levels. The most recent data indicates a decline to 2.76 as of June 2026, suggesting a decrease in the velocity of inventory movement.
Relationship Between Inventory Levels and Cost of Products Sold
The decline in turnover observed in 2023 was primarily driven by a significant increase in inventory holdings, which grew from 6.173 billion USD in December 2022 to a peak of 6.871 billion USD in June 2023. During this same window, the cost of products sold remained relatively stagnant or declined, resulting in a lower turnover ratio. A temporary recovery in efficiency occurred in December 2024, where the turnover ratio spiked to 3.02, coinciding with a reduction in inventory to 6.194 billion USD.
Recent Operational Observations
In the period leading up to June 2026, a divergence is observed between the growth of inventory and the cost of products sold. While the cost of products sold increased significantly to 5.325 billion USD in June 2026, inventory levels also rose to a period high of 7.315 billion USD. Because the growth in inventory outpaced the increase in sales costs, the inventory turnover ratio contracted from 2.82 in March 2026 to 2.76 in June 2026.


Receivables Turnover

Abbott Laboratories, receivables turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Net sales
Trade receivables, less allowances
Short-term Activity Ratio
Receivables turnover1
Benchmarks
Receivables Turnover, Competitors2
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Receivables turnover = (Net salesQ2 2026 + Net salesQ1 2026 + Net salesQ4 2025 + Net salesQ3 2025) ÷ Trade receivables, less allowances
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


Analysis of the operating activity ratios indicates a gradual erosion of receivables collection efficiency over the observed period. While net sales demonstrated resilience and eventual growth, the increase in trade receivables outpaced sales growth in the latter half of the timeframe, leading to a sustained downward trend in the turnover ratio.

Net Sales Performance
Net sales exhibited a U-shaped trajectory, starting at 11,895 million USD in March 2022 and declining to a period low of 9,747 million USD by March 2023. A subsequent recovery phase is evident, with sales steadily increasing to reach 12,593 million USD by June 2026.
Trade Receivables Dynamics
Trade receivables initially declined in alignment with sales, dropping from 7,179 million USD in March 2022 to 6,020 million USD in March 2023. However, from June 2023 onward, receivables entered a period of consistent expansion, rising to 8,599 million USD by June 2026, which exceeds the initial levels recorded at the start of the period.
Receivables Turnover Trends
The receivables turnover ratio reached a peak of 7.03 in September 2022, marking the period of highest collection efficiency. Following this peak, a consistent decline is observed. The ratio fell through 2023 and 2024, eventually reaching 5.42 by June 2026. This suggests a lengthening of the average collection period.
Operational Insights
The divergence between the recovering net sales and the accelerating growth of trade receivables indicates a reduction in the velocity of cash conversion. The transition from a turnover ratio of 7.03 to 5.42 suggests that receivables are growing at a faster rate than the revenue they generate, potentially indicating a shift in credit policies or a slowdown in customer payment cycles.


Payables Turnover

Abbott Laboratories, payables turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets
Trade accounts payable
Short-term Activity Ratio
Payables turnover1
Benchmarks
Payables Turnover, Competitors2
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Payables turnover = (Cost of products sold, excluding amortization of intangible assetsQ2 2026 + Cost of products sold, excluding amortization of intangible assetsQ1 2026 + Cost of products sold, excluding amortization of intangible assetsQ4 2025 + Cost of products sold, excluding amortization of intangible assetsQ3 2025) ÷ Trade accounts payable
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The payables turnover ratio demonstrates a pattern of moderate volatility with a consistent baseline, suggesting a disciplined approach to managing short-term obligations to suppliers throughout the observed period.

Payables Turnover Trends
The turnover ratio oscillates between a minimum of 4.02 in March 2022 and a peak of 4.69 in September 2025. This indicates a cyclical fluctuation in the frequency with which supplier obligations are settled, without showing a definitive long-term upward or downward trajectory. The ratio predominantly remains within the 4.1 to 4.7 range, reflecting a stable operational cadence in accounts payable management.
Cost of Products Sold and Payable Correlation
An overall increase in the cost of products sold is evident toward the latter part of the period, rising from a low of 4,331 million in March 2023 to a peak of 5,325 million by June 2026. During the same interval, trade accounts payable exhibited a recovery from a low of 3,961 million in September 2023 to 4,794 million in June 2026. The near-parallel movement of these two metrics suggests that the company scales its supplier financing proportionally with its production costs.
Efficiency and Credit Management Insights
The stability of the turnover ratio suggests a consistent strategy regarding credit terms and payment velocity. The rise in turnover observed between March 2024 and September 2025 indicates a period of more rapid payment cycles or a decrease in the average payable balance relative to costs. Conversely, the decline to 4.22 in the first half of 2026, despite the highest recorded costs of products sold, indicates an expansion of the trade accounts payable balance, which may reflect the utilization of extended credit terms to support increased operational volume.


Working Capital Turnover

Abbott Laboratories, working capital turnover calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data (US$ in millions)
Current assets
Less: Current liabilities
Working capital
 
Net sales
Short-term Activity Ratio
Working capital turnover1
Benchmarks
Working Capital Turnover, Competitors2
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Working capital turnover = (Net salesQ2 2026 + Net salesQ1 2026 + Net salesQ4 2025 + Net salesQ3 2025) ÷ Working capital
= ( + + + ) ÷ =

2 Click competitor name to see calculations.


The operational efficiency regarding working capital usage exhibited a period of relative stability followed by a sharp increase in turnover efficiency toward the end of the analyzed period. Throughout 2022 and 2023, the relationship between net sales and working capital fluctuated, with net sales reaching a trough in early 2023 before beginning a consistent upward trajectory.

Working Capital Trends
Working capital levels peaked at 12,564 million in June 2022, followed by a general downward trend reaching a low of 8,355 million in March 2024. Although a moderate recovery was observed throughout 2025, a significant contraction occurred in the first half of 2026, with values declining to 6,703 million by June 2026.
Net Sales Performance
Net sales experienced a contraction from March 2022 (11,895 million) to a minimum of 9,747 million in March 2023. Following this period, a sustained growth trend emerged, culminating in the highest recorded value of 12,593 million in June 2026, indicating a robust recovery and expansion of top-line revenue.
Working Capital Turnover Analysis
From March 2022 through December 2025, the working capital turnover ratio remained relatively stable, oscillating between 3.63 and 4.83. A distinct shift in efficiency is observable in the first half of 2026, where the ratio accelerated to 6.33 in March and 6.95 in June. This surge is attributable to the convergence of peak sales performance and the lowest recorded working capital levels, signaling a substantial optimization in the ability to generate revenue relative to the investment in short-term operating assets.


Average Inventory Processing Period

Abbott Laboratories, average inventory processing period calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data
Inventory turnover
Short-term Activity Ratio (no. days)
Average inventory processing period1
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ =

2 Click competitor name to see calculations.


Analysis of the operating activity ratios reveals a distinct shift in inventory management efficiency between 2022 and 2026. A transition from a lean inventory cycle to a prolonged processing period is evident, characterized by a notable increase in the time required to convert inventory into sales.

Inventory Turnover Trends
The turnover ratio remained relatively robust throughout 2022, maintaining a range between 3.10 and 3.37. A downward trend emerged in 2023, with the ratio declining to a low of 2.62 by June. While a temporary recovery was recorded in December 2024, where the ratio peaked at 3.02, the metric generally stabilized within the 2.65 to 2.88 range throughout 2025 and the first half of 2026.
Average Inventory Processing Period Analysis
The processing period exhibited a corresponding increase, rising from a 2022 average of approximately 112 days to a peak of 139 days in June 2023. This represents a significant extension of the operating cycle. Although a contraction to 121 days was observed in December 2024, the duration remained elevated relative to the 2022 baseline, ending at 132 days by June 2026.
Operational Efficiency Correlation
A consistent inverse correlation is observed between inventory turnover and the processing period. The most pronounced period of inefficiency occurred between mid-2023 and early 2024. Subsequent volatility in 2025 indicates periodic fluctuations in stock management, though the overall trajectory suggests a systemic shift toward a longer inventory holding period compared to the initial reporting period.


Average Receivable Collection Period

Abbott Laboratories, average receivable collection period calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data
Receivables turnover
Short-term Activity Ratio (no. days)
Average receivable collection period1
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ =

2 Click competitor name to see calculations.


The analyzed period reveals a general deterioration in the efficiency of receivables management, characterized by a steady increase in the time required to collect outstanding payments and a corresponding decline in the turnover ratio.

Receivables Turnover Analysis
A peak in efficiency was observed in the third quarter of 2022, where the receivables turnover reached its highest point of 7.03. Following this peak, the ratio entered a long-term downward trend, declining to 6.11 by the end of 2023 and continuing to slide to 5.42 by June 30, 2026. This decline indicates a reduction in the frequency with which the company converts its accounts receivable into cash over the observed timeframe.
Average Receivable Collection Period Trends
The collection period initially showed improvement, decreasing from 59 days in March 2022 to a minimum of 52 days by December 2022. However, a consistent upward trajectory followed this low point. The period gradually expanded throughout 2023 and 2024, reaching a peak of 68 days in June and September 2025. The period remained elevated through 2026, closing at 67 days in June 2026.
Correlation and Operational Insight
There is a direct inverse correlation between the turnover ratio and the collection period. The expansion of the collection cycle by 15 days from its lowest point (52 days) to its near-peak (67 days) suggests a slowing of cash inflows. This pattern may be attributable to a relaxation of credit policies, an increase in payment delays from customers, or changes in the credit quality of the client base.


Operating Cycle

Abbott Laboratories, operating cycle calculation (quarterly data)

No. days

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data
Average inventory processing period
Average receivable collection period
Short-term Activity Ratio
Operating cycle1
Benchmarks
Operating Cycle, Competitors2
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= + =

2 Click competitor name to see calculations.


The operating cycle exhibits a general upward trend over the analyzed period, indicating a lengthening of the time required to convert investment in inventory back into cash. The total cycle expanded from 168 days in March 2022 to 199 days by June 2026, representing a significant extension in the company's operational liquidity timeline.

Average Inventory Processing Period
A notable increase in the time required to process inventory is observed. Between March 2022 and June 2023, the period rose from 109 days to a peak of 139 days. Although a temporary contraction occurred in December 2024 to 121 days, the period remained consistently higher than 2022 levels, concluding at 132 days in June 2026. This suggests a sustained shift toward longer inventory holding times.
Average Receivable Collection Period
The collection period demonstrates a steady and gradual increase. After an initial decline to 52 days in late 2022, the period began a consistent climb starting in March 2023. The collection timeframe moved from 53 days to 67 days by June 2026. This upward trajectory indicates a slowing in the efficiency of converting accounts receivable into cash.
Operating Cycle Synthesis
The overall expansion of the operating cycle is driven by the simultaneous increase in both inventory processing and receivable collection. The most significant acceleration in the cycle occurred during 2023, where the duration jumped from 170 days in December 2022 to a peak of 195 days in June 2023. While there was a brief period of improvement in late 2024, the cycle returned to a plateau between 190 and 200 days through 2025 and 2026, reflecting a more prolonged operational cash conversion process compared to the start of the period.


Average Payables Payment Period

Abbott Laboratories, average payables payment period calculation (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data
Payables turnover
Short-term Activity Ratio (no. days)
Average payables payment period1
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ =

2 Click competitor name to see calculations.


The analysis of short-term operating activity ratios reveals a consistent and stable management of accounts payable from March 2022 through June 2026. The average payables payment period demonstrates a controlled range of fluctuation, indicating a disciplined approach to supplier credit and working capital management.

Average Payables Payment Period Trends
The payment period began at a peak of 91 days in March 2022 before experiencing a general contraction. Significant lows of 78 days were recorded in September 2022 and September 2025. Following these contractions, the period typically rebounded, stabilizing between 80 and 87 days throughout 2023 and 2024, and concluding at 87 days in June 2026. This pattern suggests periodic accelerations in payment cycles followed by a return to a baseline credit utilization strategy.
Payables Turnover Correlation
A strong inverse relationship is observed between the payables turnover ratio and the average payment period. The turnover ratio fluctuated between a minimum of 4.02 and a maximum of 4.69. Peak turnover values, specifically 4.67 in September 2022 and 4.69 in September 2025, correlate directly with the shortest payment durations of 78 days, confirming a higher frequency of supplier settlements during those periods.
Operational Liquidity Insights
The narrow variance in the turnover ratio and the relative stability of the payment period indicate a predictable cash outflow pattern. The absence of dramatic spikes or prolonged extensions in payment terms suggests that the company maintains a steady relationship with its creditors and possesses sufficient liquidity to meet its short-term obligations without relying on excessive extensions of payment terms.


Cash Conversion Cycle

Abbott Laboratories, cash conversion cycle calculation (quarterly data)

No. days

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Selected Financial Data
Average inventory processing period
Average receivable collection period
Average payables payment period
Short-term Activity Ratio
Cash conversion cycle1
Benchmarks
Cash Conversion Cycle, Competitors2
Intuitive Surgical Inc.
Medtronic PLC

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).

1 Q2 2026 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= + =

2 Click competitor name to see calculations.


The operating cycle demonstrates a clear trend of expansion, with the cash conversion cycle lengthening significantly over the analyzed period. This increase suggests a slower recovery of cash outflows associated with the production and sale of goods, primarily driven by deterioration in inventory management and receivable collection efficiency.

Average Inventory Processing Period
A notable upward shift in inventory duration is evident. Starting at 109 days in March 2022, the period peaked at 139 days by June 2023. Although a moderate reduction to 121 days occurred in December 2024, the metric stabilized at a higher plateau, ending at 132 days in June 2026. This trend indicates a general increase in the time required to convert raw materials and finished goods into sales.
Average Receivable Collection Period
The time required to collect payments from customers shows a steady and gradual increase. After a brief period of efficiency in late 2022 where the period dropped to 52 days, a consistent upward trajectory began in 2023. The collection period climbed from 53 days in March 2023 to 67 days by June 2026, reflecting a slowing trend in credit recovery and a higher reliance on accounts receivable to support sales.
Average Payables Payment Period
Payables management remained relatively stable compared to inventory and receivables. The period fluctuated within a narrow range, generally between 78 and 91 days. While there was a slight contraction in the payment window during late 2023 and throughout 2024, the period recovered to 87 days by the end of the analysis. This stability suggests that the company maintained a consistent strategy regarding its obligations to suppliers.
Cash Conversion Cycle
The aggregate effect of the increased inventory and receivable periods, coupled with stable payables, resulted in a substantial extension of the cash conversion cycle. The cycle lengthened from 77 days in March 2022 to a peak of 118 days in June 2024 and September 2025. Despite occasional fluctuations, the cycle remained consistently above 100 days from March 2023 onward, culminating in 112 days by June 2026. This expansion represents a decrease in short-term liquidity efficiency and an increase in the amount of working capital required to sustain operations.